Page last updated: 2024-10-28

ha14-1 and Cancer of Esophagus

ha14-1 has been researched along with Cancer of Esophagus in 1 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Research Excerpts

ExcerptRelevanceReference
"We examined the sensitivity of three oesophageal cancer cell lines to 5-fluorouracil (5-FU) alone and in combination with the BH3 mimetic HA14-1."1.38The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells. ( Crowley, LC; Elzinga, B; McKenna, SL; Nyhan, MJ; O'Donovan, TR; O'Sullivan, GC, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nyhan, MJ1
O'Donovan, TR1
Elzinga, B1
Crowley, LC1
O'Sullivan, GC1
McKenna, SL1

Other Studies

1 other study available for ha14-1 and Cancer of Esophagus

ArticleYear
The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.
    British journal of cancer, 2012, Feb-14, Volume: 106, Issue:4

    Topics: Autophagy; Benzopyrans; Cell Death; Cell Line, Tumor; Esophageal Neoplasms; Fluorouracil; Humans; Ni

2012